Frank Karbe

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, California
Signature
/s/ Molly Henderson, Attorney-in-Fact for Frank Karbe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Karbe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Myovant Sciences Ltd. Principal Fin'l & Accounting Common Shares 212,296 $5.73 M $27.00 Jul 7, 2021 Direct
Phathom Pharmaceuticals, Inc. Director Common Stock 44,500 $452 K $10.16 May 29, 2024 Direct
Better Therapeutics, Inc. Chief Executive Officer, Director Common Stock 526,516 $89.5 K $0.17 Dec 18, 2023 Direct
Phathom Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17,500 May 23, 2024 Direct

Insider Reports Filed by Frank Karbe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHAT Phathom Pharmaceuticals, Inc. May 29, 2024 1 254,113 4 May 31, 2024 Director
PHAT Phathom Pharmaceuticals, Inc. May 23, 2024 2 0 4 May 24, 2024 Director
BTTX Better Therapeutics, Inc. Dec 18, 2023 1 0 4 Dec 20, 2023 Chief Executive Officer, Director
BTTX Better Therapeutics, Inc. Jul 27, 2023 1 100,000 4 Jul 31, 2023 Chief Executive Officer, Director
PHAT Phathom Pharmaceuticals, Inc. May 25, 2023 2 0 4 May 30, 2023 Director
BTTX Better Therapeutics, Inc. Apr 10, 2023 1 200,000 4 Apr 12, 2023 Chief Executive Officer, President, Treasurer and Secretary, Director
BTTX Better Therapeutics, Inc. Sep 15, 2022 1 104,695 4 Sep 15, 2022 Chief Executive Officer, President, Treasurer and Secretary, Director
BTTX Better Therapeutics, Inc. Jul 5, 2022 1 0 4 Jul 7, 2022 Chief Executive Officer, President, Treasurer and Secretary, Director
BTTX Better Therapeutics, Inc. Jul 5, 2022 0 0 3 Jul 7, 2022 Chief Executive Officer, President, Treasurer and Secretary. Exhibit 24 - Power of Attorney., Director
PHAT Phathom Pharmaceuticals, Inc. May 25, 2022 1 0 4 May 27, 2022 Director
PHAT Phathom Pharmaceuticals, Inc. Apr 25, 2022 1 0 4 Apr 26, 2022 Director
PHAT Phathom Pharmaceuticals, Inc. Apr 25, 2022 0 0 3 Apr 26, 2022 Director
MYOV Myovant Sciences Ltd. Jul 7, 2021 1 -70,296 4 Jul 9, 2021 Principal Fin'l & Accounting